Future Doctor CEO Wang Shirui and Kevin Kelly Discuss How Medical AGI Could Extend Human Lifespan Beyond 120 Years

Deep News
04/09

In a recent dialogue, Kevin Kelly and Future Doctor CEO Wang Shirui explored the future of healthcare. While the conversation began with AI in medicine, it addressed a broader question: as AI reshapes healthcare systems, could human lifespan surpass 120 years?

Kevin Kelly expressed that life systems are too complex for rapid progress in life extension. He suggested that while humanity might eventually reach 120 years, it is unlikely to occur within the current generation's lifetime.

Wang Shirui offered a more optimistic outlook, stating that individuals born in the 2020s and 2030s have a strong chance of exceeding 120 years. He explained that if medical AGI achieves critical breakthroughs, the journey toward 120 years or more could accelerate significantly. Wang identified three primary factors influencing death: accidents, aging, and disease. Accidents are decreasing with social development, aging remains difficult to reverse, but disease is the area most likely to be systematically transformed by AI today. He emphasized that if "medical AGI" can eliminate deaths caused by disease, human lifespan could naturally approach 120 years based on telomere biology, which is a core focus for Future Doctor.

Wang clarified that Future Doctor is not merely developing a standard medical AI product but addressing two larger questions: how to replicate the best medical capabilities and how to accelerate the renewal of medical knowledge itself. The first relates to the present, the second to the future. He referenced the Northern Song dynasty thinker Zhang Zai's "Four Sentences from Hengqu" to define these goals as "inheriting lost knowledge" and "opening lasting peace," together forming the true significance of medical AGI.

According to the discussion, Future Doctor's platform brings together expert teams from top-tier hospitals across China, including PLA General Hospital, Peking Union Medical College Hospital, West China Hospital, Ruijin Hospital, and Huashan Hospital. The platform has exclusively signed over 50 leading experts from organizations such as the Chinese Medical Association and the Chinese Medical Doctor Association. Through long-term collaboration, Future Doctor is co-developing exclusive AI agents with these clinical experts to create new models of human-machine collaborative diagnosis and treatment. Currently, the platform has launched intelligent agents for more than 50 specialists, with over 500,000 licensed doctors signed on. This foundation supports a human-AI collaborative triage system that includes AI preliminary screening, structured consultations, multidisciplinary team involvement, specialized matching, and final review by authoritative experts.

Kevin Kelly noted that medicine, relying solely on human effort, is nearing its limits. He emphasized the need for "second brains"—AI systems skilled at processing vast amounts of data—to drive further progress. Deploying these systems throughout the healthcare ecosystem represents a genuine revolution, with Future Doctor positioned at the center of this medical paradigm evolution.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10